0000000000559840

AUTHOR

Daniel Stahl

showing 19 related works from this author

Additional file 6 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 6. Estimated optimism.

Data_FILES
researchProduct

Additional file 14 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learnin…

2021

Additional file 14. The formula for the final model.

TheoryofComputation_MATHEMATICALLOGICANDFORMALLANGUAGESData_FILES
researchProduct

Additional file 2 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 2. Distribution of missing and observed variables included in the analyses in ELSA.

researchProduct

A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT …

2020

Background People with psychotic disorders have reduced life expectancy largely because of physical health problems, especially cardiovascular disease, that are complicated by the use of tobacco and cannabis. Objectives We set out to (1) chart lifestyle and substance use choices and the emergence of cardiometabolic risk from the earliest presentation with psychosis, (2) develop a pragmatic health promotion intervention integrated within the clinical teams to improve the lifestyle choices and health outcomes of people with psychosis and (3) evaluate the clinical effectiveness and cost-effectiveness of that health promotion intervention. Design We performed a longitudinal cohort study of peo…

dysglycaemiamedicine.medical_specialtyhealth promotionMotivational interviewingmotivational interviewinglaw.invention03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled triallawIntervention (counseling)medicinepsychosis030212 general & internal medicinerctFirst episodelifestyle choicesbusiness.industrylcsh:Public aspects of medicineweightlcsh:RA1-1270waist circumferenceMental health030227 psychiatryHealth promotionquality of lifeFamily medicineLife expectancybusinessphysical healthmental healthProgramme Grants for Applied Research
researchProduct

ATXN2 trinucleotide repeat length correlates with risk of ALS

2017

We investigated a CAG trinucleotide repeat expansion in the ATXN2 gene in amyotrophic lateral sclerosis (ALS). Two new case-control studies, a British dataset of 1474 ALS cases and 567 controls, and a Dutch dataset of 1328 ALS cases and 691 controls were analyzed. In addition, to increase power, we systematically searched PubMed for case-control studies published after 1 August 2010 that investigated the association between ATXN2 intermediate repeats and ALS. We conducted a meta-analysis of the new and existing studies for the relative risks of ATXN2 intermediate repeat alleles of between 24 and 34 CAG trinucleotide repeats and ALS. There was an overall increased risk of ALS for those carry…

MaleExpansion0301 basic medicineAgingATXN2 geneSettore MED/03 - GENETICA MEDICA0302 clinical medicineTrinucleotide RepeatsGenetic Report AbstractAmyotrophic lateral sclerosisAtaxin-2GeneticsCAGGeneral NeuroscienceATXN2Triplet3. Good healthFemalePsychologyNeurovetenskaperRiskNeuroscience(all)Age of onsetClinical Neurology03 medical and health sciencesSCA2Trinucleotide repeatJournal ArticlemedicineHumansAlleleAllelesGenetic Association StudiesAmyotrophic lateral sclerosiIntermediate expansionNeuroscience (all)NeurosciencesExponential riskCase-control studyAmyotrophic lateral sclerosismedicine.diseaseClinical neurologyAgeing030104 developmental biologyCase-Control StudiesHuman medicineNeurology (clinical)ALSGeriatrics and GerontologyAge of onsetTrinucleotide Repeat ExpansionTrinucleotide repeat expansionALS; ATXN2; Age of onset; Amyotrophic lateral sclerosis; CAG; Expansion; Exponential risk; Intermediate expansion; Risk; SCA2; Trinucleotide repeat; TripletNeuroscience030217 neurology & neurosurgeryMeta-AnalysisDevelopmental BiologyNeurobiology of Aging
researchProduct

Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large pop…

2021

Abstract Background In increasingly ageing populations, there is an emergent need to develop a robust prediction model for estimating an individual absolute risk for all-cause mortality, so that relevant assessments and interventions can be targeted appropriately. The objective of the study was to derive, evaluate and validate (internally and externally) a risk prediction model allowing rapid estimations of an absolute risk of all-cause mortality in the following 10 years. Methods For the model development, data came from English Longitudinal Study of Ageing study, which comprised 9154 population-representative individuals aged 50–75 years, 1240 (13.5%) of whom died during the 10-year follo…

AgingLongitudinal studySurvivalEpidemiologyCalibration (statistics)PopulationHealth InformaticsFeature selectionAbsolute riskPopulation-based longitudinal studyPrognostic factorsRisk AssessmentSensitivity and Specificity01 natural sciencesCohort Studies010104 statistics & probability03 medical and health sciences0302 clinical medicineStatisticsHumansMedicineLongitudinal Studies030212 general & internal medicineMortality0101 mathematicseducationAgedProportional Hazards Modelslcsh:R5-920education.field_of_studyProportional hazards modelbusiness.industryAbsolute risk reductionHealth and Retirement StudyStatistical learninglcsh:Medicine (General)businessResearch ArticleCohort studyBMC Medical Research Methodology
researchProduct

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

2013

UNLABELLED: Cannabis use is associated with an earlier age of onset of psychosis (AOP). However, the reasons for this remain debated. METHODS: We applied a Cox proportional hazards model to 410 first-episode psychosis patients to investigate the association between gender, patterns of cannabis use, and AOP. RESULTS: Patients with a history of cannabis use presented with their first episode of psychosis at a younger age (mean years = 28.2, SD = 8.0; median years = 27.1) than those who never used cannabis (mean years = 31.4, SD = 9.9; median years = 30.0; hazard ratio [HR] = 1.42; 95% CI: 1.16-1.74; P < .001). This association remained significant after controlling for gender (HR = 1.39; 95% …

AdultAffective Disorders PsychoticMaleRiskage of onset cannabis drug use gender high-potency cannabis psychotic disorders survival plotsPsychosisPediatricsmedicine.medical_specialtySex FactorsDelta-9-tetrahydrocannabinolSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.medicineHumansAge of OnsetPsychiatrySettore MED/25 - PsichiatriaCannabisFirst episodebiologyProportional hazards modelHazard ratioRegular Articlemedicine.diseasebiology.organism_classificationPsychiatry and Mental healthPsychotic DisordersSchizophreniaFemaleCannabisAge of onsetPsychologySchizophrenia bulletin
researchProduct

Additional file 3 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 3. Sample calculations for Survival outcomes (Cox prediction models).

researchProduct

Additional file 12 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learnin…

2021

Additional file 12. The distribution of survival probabilities estimated based on 13 variables included in the model in the development and validation cohorts.

researchProduct

Additional file of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning m…

2021

Additional file of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large population-based cohort study and external validation

researchProduct

Additional file 4 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 4. Distributions of the variables at baseline before and after multiple imputations.

Statistics::ApplicationsStatistics::MethodologyQuantitative Biology::GenomicsComputer Science::Operating Systems
researchProduct

Additional file 8 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 8. Optimism-corrected models’ performance in prediction the 10-year risk of all-cause mortality in older adults.

researchProduct

Additional file 11 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learnin…

2021

Additional file 11. Histogram depicting distribution of prognostic index (PI) estimated based on 13 variables included in the model in the development cohort and external cohort.

researchProduct

Additional file 10 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learnin…

2021

Additional file 10. Internally validated though optimism-correction models’ discrimination for prediction the 10-year risk of all-cause mortality in older adults.

education
researchProduct

Additional file 5 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 5. Apparent coefficients for the Cox-LASSO regression for all-cause mortality during the 10-year follow-up.

researchProduct

Additional file 13 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learnin…

2021

Additional file 13. Distributions of the variables included in the final all-cause mortality model in derivation cohort (ELSA) and validation cohort (HRS).

researchProduct

Additional file 9 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 9. Apparent models’ discrimination in prediction the 10-year risk of all-cause mortality in older adults.

researchProduct

Additional file 7 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 7. Apparent models’ performance in prediction the 10-year risk of all-cause mortality in older adults.

researchProduct

Additional file 1 of Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning…

2021

Additional file 1. Outlines a list of all variables considered in the analyses and whether they have been included or excluded from the model building.

researchProduct